Half of all Americans will be diagnosed at some point in their lives with cancer, the number two killer in the United States. One of the most common types, especially among women, is breast cancer. According to the National Cancer Institute, 192,370 women will be diagnosed with breast cancer in 2009

Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. announced that their first cooperative group-sponsored randomized Phase II trial in advanced metastatic breast cancer met its primary endpoint of progression-free survival. The study evaluated Nexavar® (sorafenib) tablets in combination with the ora

The survey also found that one in five women who support breast health or breast cancer awareness causes wish they could do more, and 60 percent of women who have not supported breast cancer organizations and causes say they lack the time or money. Joining the Take A Stand virtual march provides a

A breakthrough technology adapted for breast cancer detection based in part on research originally sponsored by the Office of Naval Research (ONR) is set to air July 23 during a CNN International news segment on Vital Signs, a program hosted by Dr. Sanjay Gupta. The technology, referred to by the U

Rhode Island Hospital is one of only four sites across the country to participate in a new clinical trial called the DIGNITY Study. The study will investigate the effectiveness of a chemotherapeutic agent, ThermoDox, used in conjunction with mild hyperthermia (a form of heat therapy) for treating re

An upcoming G&D paper reveals how two specific matrix metalloproteinase (MMP) proteins contribute to bone metastasis in advanced breast cancer - lending important new insight into the design of clinically useful small molecule inhibitors. The study was led by Dr. Yibin Kang in Princeton Univers

Scientists have found a way to identify breast cancer patients at risk of heart disease after radiotherapy, according to a report published yesterday. Radiotherapy is commonly used to treat those patients who have had breast conservation surgery, and those who are at high risk of the cancer returni

Research currently underway at The Cancer Institute of New Jersey (CINJ) and CINJ-Hamilton, which may unlock the mysteries of why some women develop breast cancer at an earlier age than others, has been expanded to include more healthy volunteers than previously sought. CINJ is a Center of Excellenc

Women's Way, North Dakota's breast and cervical cancer early detection program, is expanding its services to include screening mammograms for eligible women ages 40 through 49, according to Mary Ann Foss, Women's Way program director for the North Dakota Department of Health. Previously, women ages

Women with hormone receptor (HR) negative first tumors have twice as much risk for developing a second breast cancer as women with HR-positive tumors, according to a study published online July 9 in the Journal of the National Cancer Institute. Christina A. Clarke, Ph.D., of the Northern California